MUSASHI1通过激活p38 MAPK通路来促进的酸化
Wenshuang Li1, Baomiao Ma1, Xiang Tian1
1School of Medicine, Jianghan University, 430056, Wuhan, China; Hubei Key Laboratory of Cognitive and Affective Disorders, Jianghan University, 430056 Wuhan, China; Hubei Provincial Demonstration Center for Experimental Medicine Education, School of Medicine, Jianghan University, 430056, Wuhan, China.
RNA结合蛋白MUSASHI1 (MSI1) 通过激活p38 MAPK通路,促进阿尔茨海默病 (AD) 中的Tau过酸化. 这项研究确定MSI1作为AD的潜在治疗点.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 异常的蛋白酸化是阿尔茨海默氏症 (AD) 病变的标志.
- 针对阿尔茨海默病的高酸化的治疗策略有限.
- RNA结合蛋白MUSASHI1 (MSI1) 在AD大脑中过度表达,在神经发育中起作用.
研究的目的:
- 研究MUSASHI1 (MSI1) 在高酸化和阿尔茨海默病 (AD) 病理学中的作用.
- 阐明MSI1影响陶酸化的分子机制.
- 为了确定MSI1在神经细胞中的潜在相互作用伙伴.
主要方法:
- 利用P301S转基因小鼠模型研究MSI1表达与Tau病理学相关.
- 研究了p38基激活蛋白激酶 (MAPK) 信号通路的激活.
- 进行共同免疫沉测试以确定MSI1相互作用伙伴.
主要成果:
- 在P301S小鼠模型中,随着Tau病理的进展,MSI1表达逐渐增加.
- MSI1激活了p38 MAPK信号通路,导致的酸化增加.
- 确定了两个新的微管相关蛋白质作为神经元中潜在的MSI1相互作用伙伴.
结论:
- MSI1在促进异常的陶酸化中发挥着重要作用,这是阿尔茨海默病 (AD) 中的一个关键事件.
- MSI1-p38 MAPK信号轴代表了一种新的机制,有助于AD的Tau病理.
- MSI1及其相互作用伙伴是阿尔茨海默病 (AD) 的潜在治疗点.
更多相关视频
12:47Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
Published on: December 27, 2016
09:12Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
Published on: December 20, 2019
相关概念视频
MAPK Signaling Cascades
Microtubule Associated Proteins (MAPs)
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
